Literature DB >> 2105451

Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2105451

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


× No keyword cloud information.
  13 in total

1.  Occupational HIV infection: Can we talk?

Authors:  L Nicolle
Journal:  Can J Infect Dis       Date:  1991

2.  An ethics committee's recommendations on testing patients for HIV antibodies when health care workers suffer exposure to blood-borne pathogens.

Authors:  N S Wenger; J W Ross; R T Young
Journal:  HEC Forum       Date:  1991

Review 3.  Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.

Authors:  H D Langtry; K J Palmer; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

4.  National surveillance of occupational exposure to the human immunodeficiency virus.

Authors:  M Ricketts; L Deschamps; K Elmslie; M O'Shaughnessy
Journal:  Can J Infect Dis       Date:  1992-11

Review 5.  Human immunodeficiency virus and hepatitis--implications for operating room personnel.

Authors:  S Colbert; G J Sheehan
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

6.  Controversies in the management of HIV-related illnesses.

Authors:  M Cooke; H Libman; M D Smith; T G Cooney; H Hollander; H J Makadon; P A Volberding
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

Review 7.  Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.

Authors:  L M Lee; D K Henderson
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

8.  Feline immunodeficiency virus infection: plasma, but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine.

Authors:  J Meers; G M del Fierro; R B Cope; H S Park; W K Greene; W F Robinson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Medical decision analysis in infectious diseases.

Authors:  U D Allen
Journal:  Can J Infect Dis       Date:  2000-11

Review 10.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.